Position in IDYA
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$44,431,485
+$11,975,201 QoQ
Shares Held
1,333,478
+42.0% QoQ
Ownership
1.52%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 89.20064672982981.ToString("F0")%
Shared 6.70659733418924.ToString("F0")%
None 4.0927559359809464.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. IDYA ranks #30 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in IDYA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $44,431,485 | 1,333,478 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $32,456,284 | 938,857 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $13,524,674 | 497,048 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,587,525 | 170,672 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,330,005 | 81,197 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $8,911,859 | 346,765 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $11,922,860 | 376,353 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $38,440,954 | 1,094,872 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $59,867,193 | 1,364,339 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $45,766,552 | 1,286,300 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $30,817,688 | 1,142,242 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $25,529,200 | 1,086,349 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $14,230,470 | 1,036,451 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $13,215,330 | 727,316 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $8,882,352 | 595,332 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $6,854,859 | 496,729 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,757,797 | 425,183 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $6,433,886 | 272,161 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $2,337,178 | 91,690 | Shares | Defined | 2021-11-12 | |
| 2020-12-31 | $574,938 | 41,067 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $354,832 | 28,251 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||